1.北京市平谷区中医医院肾病科,北京 101200
2.首都医科大学附属北京中医医院肾病科,北京 100010
扫 描 看 全 文
杨俊,赵春芝,张磊,等.桃红四物汤合五苓散加减联合氢氯噻嗪治疗慢性肾衰竭血瘀水湿证的临床研究[J].北京中医药,2022,41(11):1305-1309.
YANG Jun,ZHAO Chun-zhi,ZHANG Lei,et al.Clinical Study of modified Taohong Siwu Decoction and Wuling Powder combined with hydrochlorothiazide in treating chronic renal failure with blood stasis and water damp syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(11):1305-1309.
杨俊,赵春芝,张磊,等.桃红四物汤合五苓散加减联合氢氯噻嗪治疗慢性肾衰竭血瘀水湿证的临床研究[J].北京中医药,2022,41(11):1305-1309. DOI: 10.16025/j.1674-1307.2022.11.025.
YANG Jun,ZHAO Chun-zhi,ZHANG Lei,et al.Clinical Study of modified Taohong Siwu Decoction and Wuling Powder combined with hydrochlorothiazide in treating chronic renal failure with blood stasis and water damp syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(11):1305-1309. DOI: 10.16025/j.1674-1307.2022.11.025.
目的,2,探讨桃红四物汤合五苓散加减联合氢氯噻嗪治疗慢性肾衰竭(CRF)血瘀水湿证的临床疗效。,方法,2,选择首都医科大学附属北京中医医院及北京市平谷区中医医院肾病科门诊2018年4月—2020年5月收治的CRF血瘀水湿证患者60例,按照随机数字表法分为观察组和对照组各30例。对照组给予常规治疗+口服氢氯噻嗪片,观察组在对照组基础上联合桃红四物汤合五苓散加减治疗,疗程2个月。所有受试者治疗前后进行中医证候积分、36项健康调查简表(SF-36)及急性生理和慢性健康状况评分Ⅱ(APACHEⅡ)评分,并检测肾功能指标血清肌酐(Cr)、尿素氮(BUN)水平及24 h尿蛋白定量(24 h-UTP),以及血清炎症指标,包括白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)浓度,统计不良反应发生情况。,结果,2,观察组总有效率为90.0%,对照组为60.0%,2组比较差异有统计学意义(,P,<,0.01)。与治疗前比较,治疗后2组中医证候积分均降低(,P,<,0.01),观察组低于对照组(,P,<,0.01)。与治疗前比较,治疗后2组血清Cr、BUN、IL-6、TNF-α、CRP及24 h-UTP均降低(,P,<,0.01),观察组指标低于对照组(,P,<,0.01)。与治疗前比较,治疗后2组SF-36评分均升高(,P,<,0.05),APACHEⅡ评分均降低(,P,<,0.01);与对照组比较,治疗后观察组SF-36评分升高,APACHEⅡ评分降低(,P,<,0.01)。2组不良反应均较少且轻微。,结论,2,桃红四物汤合五苓散加减联合氢氯噻嗪治疗CRF血瘀水湿证能显著下调患者血清相关炎症因子的表达水平,改善肾功能,安全且有效。
Objective,2,To explore the clinical effect of modified Taohong Siwu Decoction and Wuling Powder combined with hydrochlorothiazide on chronic renal failure(CRF)with blood stasis and water damp syndrome.,Methods,2,60 CRF patients with blood stasis and water dampness syndrome received by Department of Nephrology of Beijing Hospital of Traditional Chinese Medicine Affiliated to the Capital Medical University and Beijing Pinggu District Hospital of Traditional Chinese Medicine from April 2018 to May 2020 were selected and divided into observation group (,n,=30) and control group (,n,=30) . All patients were given the same routine treatment plus orally taking hydrochlorothiazide,and on the basis of treatment in observation group, the control group also combined modified Taohong Siwu Tang plus Wuling Powder treatment, with the treatment course of 2 months. Before and after treatment,TCM syndrome score, 36 Health Survey Synopsis (SF-36), acute physiological and chronic health condition score II (Apache II) , renal function index including serum creatinine (CR) , urea nitrogen (Bun) level and 24h-UTP , inflammatory index including serum interleukin-6(IL-6),tumor necrosis factor factor (TNF-α), c-reactive protein (CRP) concentration were measured.,Results,2,The total effective rate of the observation group was 90.00% (27/30) , which was significantly higher than that of the control group (60.00%,18/30)(,P,<,0.01) . Compared with that before treatment, TCM syndrome scores of both two groups were decreased after treatment (,P,<,0.01), and the observation group was lower than the control group (,P,<,0.01). The levels of CR, Bun, IL-6, TNF-α, CRP and 24h-UTP in the two groups after treatment were significantly lower than those before treatment (,P,<,0.05) , but the levels of above index in the observation group were significantly lower than those in the control Group (,P,<,0.01). Compared with that of the control group,SF-36 scores were significantly increased (,P,<,0.01) and Apache II scores were significantly decreased (,P,<,0.01) in both groups after treatment, and SF-36 scores were significantly higher (,P,<,0.01) and Apache II scores were significantly lower (,P,<,0.01) in the observation group than in the control group. The side effects were few and mild in both groups.,Conclusion,2,Modified Taohong Siwu Decoction and Wuling Powder combined with hydrochlorothiazide can effectively and safely decrease the expression of serum inflammatory factors in CRF patients with blood stasis and dampness syndrome,and improve their renal function.
桃红四物汤五苓散氢氯噻嗪慢性肾衰竭血瘀水湿证
Taohong Siwu DecoctionWuling Powderhydrochlorothiazidechronic kidney failureblood stasis and dampness syndrome
任志龙,张璐,刘杰,等.高通量血液透析对慢性肾衰竭尿毒症患者肺总量、免疫球蛋白水平及生活质量的影响[J].医学临床研究,2017,34(1):8-11.
DE DONATIS D,PORCELLI S, SERRETTI A, et al. Serum aripiprazole concentrations prehemodialysis and posthemodialysis in a schizophrenic patient with chronic renal failure: a case report[J]. J Clin Psychopharmacol, 2020,40(2):200-202.
鲁珍珍,陈万佳,刘旺意,等.中医内治法和外治法治疗慢性肾衰竭的研究进展[J].中国中西医结合肾病杂志,2018,19(3):277-279.
钱呈.中医综合治疗早中期慢性肾功能衰竭脾肾气虚证疗效观察[J].安徽中医药大学学报,2018,37(3):13-16.
王海燕.肾脏病学[M].北京:人民卫生出版社,2008:1391-1395.
EKNOYAN G,LEVIN NW.Impact of the new K/DOQI guidelines[J].Blood Purif, 2002,20(1):103-108.
国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:93-94.
郑莜萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:167-168.
李鲁,王红妹,沈毅.SF-36健康调查量表中文版的研制及其性能测试[J].中华预防医学杂志,2002,36(2):109-113.
KNAUS WA,DRAPER EA,WAGNER DP,et al.APACHE II: a severity of disease classification system[J].Crit Care Med,1985,13(10):818-829.
叶任高,陈裕盛,方敬爱.肾脏病诊断与治疗及疗效标准专题讨论纪要[J].中国中西医结合肾病杂志,2003,4(6):249-251.
吕睿婷,吕睿倩,马聪.肾衰宁胶囊联合氢氯噻嗪治疗慢性肾功能衰竭的临床研究[J].现代药物与临床,2019,34(12):3638-3641.
朱远亭,陈欣,唐雪敏,等.非洛地平缓释片联合百令胶囊治疗慢性肾脏病对改善肾功能指标的影响[J].世界中医药,2021,16(11):1746-1749.
李双,黄炜,韩晓东,等.益气活血方治疗慢性肾脏病尿蛋白的临床研究[J].中华中医药学刊,2022,40(4):230-233.
AZEEZ SH,RAFIQ S.Proinflammatory cytokine IL-6-174G/C(rs1800795)gene polymorphism among patients with chronic renal failure[J].Invest Clin,2019,60(3):221-232.
高樱,杨龙飞,翟阳,等.具有活血化瘀功效的中药药理作用及机制研究进展[J].中华中医药杂志,2018,33(11):5053-5056.
曹铭晨,于振英,辛兆洋,等.基于网络药理学的五苓散多成分-多靶点-多通路作用机制研究[J].山东科学,2020,33(1):51-60.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution